Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)

Clinical trial NCT00106184 · COMPLETED

Trial details

NCT number: NCT00106184
Sponsor: University of Pittsburgh
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myositis Dermatomyositis Polymyositis Juvenile Dermatomyositis

Start date: 2006-03-01
Primary completion: 2010-02-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.